HDR UK Gateway
HDR Gateway logo

Bookmarks

UK BioLAM

Population Size

300

People

Population Size statistic card

Years

2004

Years statistic card

Associated BioSamples

Other

Associated BioSamples statistic card

Geographic coverage

United Kingdom

England

Geographic coverage statistic card

Lead time

Not applicable

Lead time statistic card

Summary

Lymphangioleiomyomatosis (LAM) is a multi-system disease of women. Metabolomics have been used to determine if metabolites downstream of mTOR and other LAM realted pathways were present or related to disease progression in a national cohort.

Documentation

Lymphangioleiomyomatosis (LAM) is a rare lung and lymphatic disease categorised by infiltration of smooth muscle type cells in the lungs and lymphatics leading to progressive respiratory impairment. The disease only effects women and is caused by a defect in one of the two proteins associated with tuberous sclerosis, tuberin and hamartin.

Dataset type

Health and disease

Dataset population size

300

Keywords

Observations

Observed Node

Disambiguating Description

Measured Value

Measured Property

Observation Date

Persons

300

Count

01 Oct 2004

Provenance

Purpose of dataset collection

Study

Source of data extraction

Paper-based

Collection source setting

Secondary care - In-patients

Image contrast

Not stated

Biological sample availability

Other

Structural Metadata

Details

Publishing frequency

Other

Version

1.0.6

Modified

10/11/2025

Coverage

Start date

01/10/2004

Time lag

Variable

Geographic coverage

United Kingdom, England

Minimum age range

18

Maximum age range

65

Follow-up

Unknown

Accessibility

Language

en

Alignment with standardised data models

OTHER

Controlled vocabulary

LOCAL

Format

CSV

Data Access Request

Dataset pipeline status

Not available

Access rights

In Progress

Time to dataset access

Not applicable

Data Controller

Professor Simon Johnson

Dataset Types: Health and disease

Collection Sources: Secondary care - In-patients